Molecular and genetic technologies for the diagnosis of monogenic forms of urinary stone disease: clinical cases
DOI: https://dx.doi.org/10.18565/urology.2020.3.81-86
M.M. Litvinova, T.V. Filippova, D.V. Svetlichnaya, S.L. Morozov, I.S.Chugunov, S.Z. Nuralieva, V.I. Rudenko, Z.K. Gadzhieva, T.I. Subbotina, M.V. Shumikhina
1) I.M. Sechenov First Moscow State Medical University of Ministry of Public Health of the Russian Federation (Sechenov University), Moscow, Russia; 2) The Loginov Moscow Clinical Scientific Center of Moscow Health Department, Moscow, Russia; 3) Moscow Regional Research and Clinical Institute (MONIKI), Moscow, Russia; 4) Veltischev Research and Clinical Institute for Pediatrics, Moscow, Russia; 5) Endocrinology Research Center, Ministry of Health of Russia, Moscow, Russia; 6) N.F. Filatov Children’s City Hospital of Moscow Healthcare Ministry, Moscow, Russia
Kidney stone disease (KSD) is an actual problem of modern health care. By now, more than 80 monogenic forms of urolithiasis have been described. To diagnose such forms of KSD different molecular genetic technologies are used. In the current article 5 clinical cases of KSD among the patients aged 1-9 years old are presented. All of them underwent comprehensive instrumental, clinical, laboratory and molecular genetic investigations. DNA analysis was carried out by Next Generation Sequencing method (NGS) (target NGS-panels and Whole Exome Sequencing).
In all cases the molecular genetic cause of the disease was found – idiopathic infantile hypercalcemia type 1 (gene CYP24A1 – 3 cases) and cystinuria (gene SLC7A9 – 2 case). Several unknown genetic variants were found in CYP24A1 (c.1379G>T, c.1156A>T, c.1286T>C) and SLC7A9 (c.920T>A). The importance of genetic testing and the role of genetic counseling for patients with KSD were shown.
Keywords:
medullary nephrocalcinosis,
cystinuria,
genetic testing,
monogenic forms,
SLC7A9,
CYP24A1,
genetic diagnostics,
kidney stone disease,
hypercalcemia,
gene,
urolithiasis
About the Autors
Corresponding author: M.M. Litvinova – Ph.D, associate professor at the Department of Medical Genetics of I.M. Sechenov First Moscow State Medical University of Ministry of Public Health of Russian Federation (Sechenov University), Moscow, Russia; clinical geneticist at the Loginov Moscow Clinical Scientific Center of Moscow Health Department, Moscow, Russia; e-mail: mariya.litvinova@gmail.com
Similar Articles